TY - STD TI - World Health Organization. Dementia: a public health priority. Available from: URL: https://www.who.int/mental_health/publications/dementia_report_2012/en/. UR - https://www.who.int/mental_health/publications/dementia_report_2012/en/ ID - ref1 ER - TY - JOUR AU - Chan, K. Y. AU - Wang, W. AU - Wu, J. J. PY - 2013 DA - 2013// TI - Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)60221-4 DO - 10.1016/S0140-6736(13)60221-4 ID - Chan2013 ER - TY - JOUR AU - Tan, C. C. AU - Yu, J. T. AU - Wang, H. F. PY - 2014 DA - 2014// TI - Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis JO - J Alzheimers Dis VL - 41 UR - https://doi.org/10.3233/JAD-132690 DO - 10.3233/JAD-132690 ID - Tan2014 ER - TY - STD TI - NICE National Institute for Health and Care Excellence. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. Available from: URL: http://www.nice.org.uk/guidance/TA217/chapter/1-guidance. UR - http://www.nice.org.uk/guidance/TA217/chapter/1-guidance ID - ref4 ER - TY - JOUR AU - Gong, Y. AU - Chang, L. AU - Viola, K. L. PY - 2003 DA - 2003// TI - Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1834302100 DO - 10.1073/pnas.1834302100 ID - Gong2003 ER - TY - JOUR AU - Masters, C. L. AU - Cappai, R. AU - Barnham, K. J. AU - Villemagne, V. L. PY - 2006 DA - 2006// TI - Molecular mechanisms for Alzheimer’s disease: implications for neuroimaging and therapeutics JO - J Neurochem VL - 97 UR - https://doi.org/10.1111/j.1471-4159.2006.03989.x DO - 10.1111/j.1471-4159.2006.03989.x ID - Masters2006 ER - TY - JOUR AU - Panza, F. AU - Solfrizzi, V. AU - Imbimbo, B. P. AU - Logroscino, G. PY - 2014 DA - 2014// TI - Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return? JO - Expert Opin Biol Ther VL - 14 UR - https://doi.org/10.1517/14712598.2014.935332 DO - 10.1517/14712598.2014.935332 ID - Panza2014 ER - TY - JOUR AU - Castello, M. A. AU - Jeppson, J. D. AU - Soriano, S. PY - 2014 DA - 2014// TI - Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease JO - BMC Neurol VL - 14 UR - https://doi.org/10.1186/s12883-014-0169-0 DO - 10.1186/s12883-014-0169-0 ID - Castello2014 ER - TY - JOUR AU - Doody, R. S. AU - Thomas, R. G. AU - Farlow, M. PY - 2014 DA - 2014// TI - Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1312889 DO - 10.1056/NEJMoa1312889 ID - Doody2014 ER - TY - JOUR AU - Salloway, S. AU - Sperling, R. AU - Fox, N. C. PY - 2014 DA - 2014// TI - Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1304839 DO - 10.1056/NEJMoa1304839 ID - Salloway2014 ER - TY - JOUR AU - Liao, M. Q. AU - Tzeng, Y. J. AU - Chang, L. Y. PY - 2007 DA - 2007// TI - The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides JO - FEBS Lett VL - 581 UR - https://doi.org/10.1016/j.febslet.2007.02.026 DO - 10.1016/j.febslet.2007.02.026 ID - Liao2007 ER - TY - STD TI - Maji SK, Ogorzalek Loo RR, et al. Amino acid position-specific contributions to amyloid beta-protein oligomerization 2009, 284(35):23580–23591. ID - ref12 ER - TY - JOUR AU - Wang, T. PY - 2017 DA - 2017// TI - New drug research and development for Alzheimer’s pathology: present and prospect JO - Shanghai Arch Psychiatry VL - 29 ID - Wang2017 ER - TY - JOUR AU - Wang, X. AU - Sun, G. AU - Feng, T. PY - 2019 DA - 2019// TI - Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression JO - Cell Res VL - 29 UR - https://doi.org/10.1038/s41422-019-0216-x DO - 10.1038/s41422-019-0216-x ID - Wang2019 ER - TY - JOUR AU - Kong, L. N. AU - Geng, M. Y. AU - Mu, L. AU - Xin, X. L. AU - Yang, N. AU - Zuo, P. P. PY - 2005 DA - 2005// TI - Effects of acidic oligose on differentially expressed genes in the mice model of Alzheimer’s disease by microarray JO - Acta Pharm Sin VL - 40 ID - Kong2005 ER - TY - JOUR AU - Fan, Y. AU - Hu, J. AU - Li, J. PY - 2005 DA - 2005// TI - Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms JO - Neurosci Lett VL - 374 UR - https://doi.org/10.1016/j.neulet.2004.10.063 DO - 10.1016/j.neulet.2004.10.063 ID - Fan2005 ER - TY - JOUR AU - Hu, J. AU - Geng, M. AU - Li, J. PY - 2004 DA - 2004// TI - Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein JO - J Pharmacol Sci VL - 95 UR - https://doi.org/10.1254/jphs.FPJ04004X DO - 10.1254/jphs.FPJ04004X ID - Hu2004 ER - TY - JOUR AU - Jiang, R. W. AU - Du, X. G. AU - Zhang, X. PY - 2013 DA - 2013// TI - Synthesis and bioassay of beta-(1,4)-D-mannans as potential agents against Alzheimer’s disease JO - Acta Pharmacol Sin VL - 34 UR - https://doi.org/10.1038/aps.2013.104 DO - 10.1038/aps.2013.104 ID - Jiang2013 ER - TY - JOUR AU - Folstein, M. F. AU - Folstein, S. E. AU - McHugh, P. R. PY - 1975 DA - 1975// TI - “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician JO - J Psychiatr Res VL - 12 UR - https://doi.org/10.1016/0022-3956(75)90026-6 DO - 10.1016/0022-3956(75)90026-6 ID - Folstein1975 ER - TY - STD TI - Katzman R, Zhang MY, Ouang-Ya-Qu, et al. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988, 41:971–978. ID - ref20 ER - TY - JOUR AU - Hachinski, V. C. AU - Iliff, L. D. AU - Zilhka, E. PY - 1975 DA - 1975// TI - Cerebral blood flow in dementia JO - Arch Neurol VL - 32 UR - https://doi.org/10.1001/archneur.1975.00490510088009 DO - 10.1001/archneur.1975.00490510088009 ID - Hachinski1975 ER - TY - JOUR AU - Hamilton, M. PY - 1960 DA - 1960// TI - A rating scale for depression JO - J Neurol Neurosurg Psychiatry VL - 23 UR - https://doi.org/10.1136/jnnp.23.1.56 DO - 10.1136/jnnp.23.1.56 ID - Hamilton1960 ER - TY - JOUR AU - Boothby, H. AU - Mann, A. H. AU - Barker, A. PY - 1995 DA - 1995// TI - Factors determining inter rater agreement with rating global change in dementia: the cibic-plus JO - Int J Geriat Psychiatry VL - 10 UR - https://doi.org/10.1002/gps.930101208 DO - 10.1002/gps.930101208 ID - Boothby1995 ER - TY - JOUR AU - Galasko, D. AU - Bennett, D. AU - Sano, M. PY - 1997 DA - 1997// TI - An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study JO - Alzheimer Dis Assoc Disord VL - 11 UR - https://doi.org/10.1097/00002093-199700112-00005 DO - 10.1097/00002093-199700112-00005 ID - Galasko1997 ER - TY - JOUR AU - Cumming, J. L. AU - Mega, M. AU - Gray, K. AU - Rosenberg-Thompson, S. AU - Carusi, D. A. AU - Gornbein, J. PY - 1994 DA - 1994// TI - The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia JO - Neurology. VL - 44 UR - https://doi.org/10.1212/WNL.44.12.2308 DO - 10.1212/WNL.44.12.2308 ID - Cumming1994 ER - TY - JOUR AU - Wang, T. AU - Xiao, S. AU - Li, X. PY - 2012 DA - 2012// TI - Reliability and validity of the Chinese version of the neuropsychiatric inventory in mainland China JO - Int J Geriat Psychiatry. VL - 27 UR - https://doi.org/10.1002/gps.2757 DO - 10.1002/gps.2757 ID - Wang2012 ER - TY - JOUR AU - Rosen, W. G. AU - Mohs, R. C. AU - Davis, K. L. PY - 1984 DA - 1984// TI - A new rating scale for Alzheimer’s disease JO - Am J Psychiatry VL - 141 UR - https://doi.org/10.1176/ajp.141.11.1356 DO - 10.1176/ajp.141.11.1356 ID - Rosen1984 ER - TY - JOUR AU - Wilcock, G. K. AU - Lilienfeld, S. AU - Gaens, E. PY - 2000 DA - 2000// TI - Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre randomised controlled trial. Galantamine International-1 Study Group JO - BMJ. VL - 321 UR - https://doi.org/10.1136/bmj.321.7274.1445 DO - 10.1136/bmj.321.7274.1445 ID - Wilcock2000 ER - TY - JOUR AU - Rogers, S. L. AU - Friedhoff, L. T. PY - 1996 DA - 1996// TI - The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group JO - Dementia VL - 7 ID - Rogers1996 ER - TY - JOUR AU - Salloway, S. AU - Sperling, R. AU - Fox, N. C. PY - 2014 DA - 2014// TI - Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1304839 DO - 10.1056/NEJMoa1304839 ID - Salloway2014 ER - TY - JOUR AU - Khan, A. AU - Fahl Mar, K. AU - Faucett, J. AU - Khan Schilling, S. AU - Brown, W. A. PY - 2017 DA - 2017// TI - Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013 [published correction appears in World Psychiatry. 2017;16(3):328] JO - World Psychiatry VL - 16 UR - https://doi.org/10.1002/wps.20421 DO - 10.1002/wps.20421 ID - Khan2017 ER - TY - JOUR AU - Geuter, S. AU - Koban, L. AU - Wager, T. D. PY - 2017 DA - 2017// TI - The cognitive neuroscience of placebo effects: concepts, predictions, and physiology JO - Annu Rev Neurosci VL - 40 UR - https://doi.org/10.1146/annurev-neuro-072116-031132 DO - 10.1146/annurev-neuro-072116-031132 ID - Geuter2017 ER - TY - JOUR AU - Tachibana, Y. AU - Narukawa, M. PY - 2013 DA - 2013// TI - Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis JO - Clin Drug Investig VL - 33 UR - https://doi.org/10.1007/s40261-013-0077-x DO - 10.1007/s40261-013-0077-x ID - Tachibana2013 ER - TY - JOUR AU - Allgaier, M. AU - Allgaier, C. PY - 2014 DA - 2014// TI - An update on drug treatment options of Alzheimer’s disease JO - Front Biosci (Landmark Ed) VL - 19 UR - https://doi.org/10.2741/4285 DO - 10.2741/4285 ID - Allgaier2014 ER - TY - JOUR AU - Chen, Z. AU - Zhong, C. PY - 2013 DA - 2013// TI - Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies JO - Prog Neurobiol VL - 108 UR - https://doi.org/10.1016/j.pneurobio.2013.06.004 DO - 10.1016/j.pneurobio.2013.06.004 ID - Chen2013 ER -